CPM (carboxypeptidase M) is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein. CPM belongs to the family of carboxypeptidases, and specifically removes C-terminal basic residues (Arg or Lys) from peptides and proteins. It plays a role in controlling peptide hormone and growth factor activity and extracellular protein degradation. CPM is associated with well-differentiated liposarcoma and is a marker for the maturation of monocytes to macrophages and for iPS cell-derived liver progenitor cells.
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Clonality | Monoclonal IgG1 |
| Host | Mouse |
| Formulation | 10 ug/100 uL in PBS/50% glycerol, pH 7.2 |
| Storage | |
| Documents & Links for Anti-CPM mAb (Clone: C3-1) | |
| Datasheet | Anti-CPM mAb (Clone: C3-1) Datasheet |
| Documents & Links for Anti-CPM mAb (Clone: C3-1) | |
| Datasheet | Anti-CPM mAb (Clone: C3-1) Datasheet |
| Citations for Anti-CPM mAb (Clone: C3-1) – 2 Found |
| Kido, Taketomo; Koui, Yuta. Induction of Functional Hepatocytes from Human iPSCs. Methods In Molecular Biology (Clifton, N.j.). 1905:131-142. PubMed - Comments: Used in: FCM |
| Kido, Taketomo; Koui, Yuta. Induction of Functional Hepatocytes from Human iPSCs. Methods In Molecular Biology (Clifton, N.j.). 1905:131-142. PubMed - Comments: Used in: FCM |